← Johnson & Johnson
Episodes featuring Johnson & Johnson
184 episodes, newest first.
- Nov 20, 2026
Nvidia sell-off exposes wider cracks in the AI tradeCNBC's "Fast Money"Nov 20, 2026 - Nov 20, 2026
AI valuations meet public-market realityThe Compound and FriendsNov 20, 2026 - Nov 19, 2026
Anthropic’s debut tests AI valuations as markets retreatCNBC's "Fast Money"Nov 19, 2026 - Nov 18, 2026
Target’s Pokémon surge tests retail momentumBrew MarketsNov 18, 2026 - Nov 18, 2026
AI’s infrastructure boom collides with human agencyTBPNNov 18, 2026 - Nov 17, 2026
NVIDIA weighs Jensen Huang’s return amid board scrutinyTech Brew Ride HomeNov 17, 2026 - Nov 17, 2026
Biotech bets meet a pivotal FDA succession fightBioCentury This WeekNov 17, 2026 - Nov 17, 2026
AI panic tests NVIDIA’s dominance as markets rotateMad Money w/ Jim CramerNov 17, 2026 - Nov 16, 2026
AI valuation fears put NVIDIA and Anthropic in the spotlightClosing BellNov 16, 2026 - Nov 16, 2026
Washington targets NVIDIA’s overseas China chip accessBrew MarketsNov 16, 2026 - Nov 16, 2026
Anthropic IPO tests AI trade as Nvidia faces mounting pressureBloomberg IntelligenceNov 16, 2026 - Nov 16, 2026
Prepare for a crash without abandoning the marketRich Habits PodcastNov 16, 2026 - Nov 14, 2026
Podcast panel tests accountability across politics, media and businessThe Joe Budden PodcastNov 14, 2026 - Nov 14, 2026
FAA outage tests infrastructure as investors reassess AI spendingCNBC's "Fast Money"Nov 14, 2026 - Nov 13, 2026
AI financing risks collide with Nvidia leadership uncertaintyClosing BellNov 13, 2026 - Nov 13, 2026
Rivera maps the hidden forces behind health misinformationTED Radio HourNov 13, 2026 - Nov 12, 2026
Nvidia shock exposes fragile foundations beneath the AI tradeCNBC's "Fast Money"Nov 12, 2026 - Nov 12, 2026
Larry McDonald warns AI finance could trigger a Lehman-style shockThe Julia La Roche ShowNov 12, 2026 - Nov 12, 2026
AI infrastructure faces its profitability testMad Money w/ Jim CramerNov 12, 2026 - Nov 10, 2026
AI chip controls deepen the U.S.-China technology divideWSJ What’s NewsNov 10, 2026 - Nov 9, 2026
AbbVie builds a risk-managed neuroscience portfolioBusiness Of BiotechNov 9, 2026 - Nov 6, 2026
Election stakes meet biotech’s regulatory and pipeline risksBiotech HangoutNov 6, 2026 - Nov 5, 2026
Midterms test America’s AI infrastructure boomClaude AI DailyNov 5, 2026 - Nov 5, 2026
Midterms put AI infrastructure and regulation under pressureThe AI PodcastNov 5, 2026